New anthracycline derivatives: what for?
Mross
K
K
University Clinic Eppendorf, Department Oncology and Hematology, Hamburg, Germany.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000139:chemically induced; D004351:Drug Resistance; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D013329:Structure-Activity Relationship
D000903:Antibiotics, Antineoplastic